Research Library
Evidence-based research guides, scientific articles, and educational resources on BPC-157, Semaglutide, Retatrutide, metabolic research, tissue repair and more. Updated regularly for laboratory and independent research.
In-Depth Compound Guides
KLOW Peptide Blend: Complete Research Guide to KPV, GHK-Cu, BPC-157 and TB-500
KLOW is a four-peptide research blend containing KPV (Lys-Pro-Val), GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), BPC-157 (Body Protection Compound-157) and TB-500 (synthetic Thymosin β-4). It is the four-component evolution of the three-peptide GLOW stack, and the addition is KPV. Each component acts on a different part of the tissue-repair cascade — NF-κB inflammatory signalling, extracellular matrix remodelling, local VEGF-mediated angiogenesis, and systemic actin-mediated cell migration respectively. All material is supplied for in-vitro laboratory research use only.
Research GuideGLOW vs KLOW Peptide Blend: Composition, Mechanisms and Research Differences
GLOW and KLOW are the same regenerative research formulation with one difference: KLOW contains KPV. GLOW is a three-peptide blend of GHK-Cu, BPC-157 and TB-500. KLOW is those same three peptides plus KPV (Lys-Pro-Val, C16H30N4O4, 342.4 Da, CAS 67727-97-3), the C-terminal tripeptide fragment of α-melanocyte-stimulating hormone, which contributes NF-κB-directed anti-inflammatory activity and gut-barrier research relevance. No published study has compared the two formulations head to head, so the incremental contribution of KPV is inferred from single-compound literature rather than measured directly.
Research GuideKLOW Peptide Research Protocol: 80mg Vial Reconstitution and Concentration Guide
An 80 mg KLOW vial reconstituted with 2.5 mL of bacteriostatic water gives 32 mg/mL of total blend mass. The governing relationship is arithmetic, not a protocol: concentration (mg/mL) equals peptide mass (mg) divided by diluent volume (mL). At 2 mL that is 40 mg/mL, at 3 mL 26.67 mg/mL, at 4 mL 20 mg/mL — every figure expressed as total blend mass, never as the concentration of any single peptide. Per-component concentration requires the compositional ratio printed on the batch Certificate of Analysis. This page is solution-preparation guidance for in-vitro laboratory work. It contains no dosing schedule, no administration route and no frequency chart, because no pharmacokinetic study of KLOW as a four-peptide blend has been published and the material is not supplied for use in any living subject.
Research GuideBPC-157 + TB-500 Wolverine Stack: Complementary Mechanisms in Tissue Repair Research
BPC-157 and TB-500 act at different points of the tissue-repair cascade, which is why they are studied together rather than treated as interchangeable. BPC-157 (15 residues, GEPPPGKPADDAGLV, C62H98N16O22, 1,419.5 Da, CAS 137525-51-0) upregulates VEGF and activates focal adhesion kinase and paxillin where it is introduced. TB-500 (synthetic Thymosin β-4, C212H350N56O78S, 4,963.4 Da, CAS 77591-33-4, carrying the LKKTET actin-binding motif at residues 17–22) sequesters monomeric G-actin, releasing the cytoskeletal brake on cell migration. That sequential reading is a mechanistic inference drawn from two separate single-compound literatures — no published study has run the two compounds together and measured the result, and both are supplied for in-vitro laboratory research only.
Research GuideGHK-Cu Copper Peptide: Research Guide to Collagen Synthesis, Tissue Remodeling and Anti-Aging Studies
GHK-Cu is glycyl-L-histidyl-L-lysine coordinated with a copper(II) ion — molecular formula C14H24CuN6O4, molecular weight 403.9 Da as the copper complex against 340.4 Da for the free tripeptide. In cell-culture models it signals dermal fibroblasts to upregulate collagen transcription through direct effects on collagen gene expression while simultaneously activating matrix metalloproteinases 1 and 2, so the net effect studied is matrix turnover rather than matrix accumulation. A second, mechanistically separate arm is proposed to deliver bioavailable copper to lysyl oxidase, the enzyme that crosslinks collagen and elastin fibrils. GHK-Cu is not FDA-approved for human therapeutic use and is supplied for in-vitro laboratory research only.
Research GuideTesamorelin Research Guide: GHRH Analog Mechanism, IGF-1 Signaling and Laboratory Protocols
Tesamorelin is a stabilized 44-residue analog of growth hormone-releasing hormone — C221H366N72O67S, 5,135.9 Da, CAS 218949-48-5 — carrying a trans-3-hexenoyl cap at the N-terminus that blocks the dipeptidyl peptidase IV cleavage which destroys native GHRH within minutes. It binds GHRH-R on anterior pituitary somatotrophs, driving pulsatile endogenous growth hormone release that leaves hypothalamic somatostatin feedback intact, which exogenous HGH does not. Downstream, GH drives hepatic IGF-1 production and raises lipolytic tone, with selectivity for visceral over subcutaneous adipose depots reported in the trial program and not yet mechanistically explained. Tesamorelin is the rare research-catalog compound holding a current FDA approval — as the drug product EGRIFTA SV, for one indication in one patient population. That approval covers the manufactured pharmaceutical. It does not extend to research-market material, which is supplied for in-vitro laboratory research only.
Research GuideResearch Peptides USA: A Sourcing Guide to HPLC-Verified Laboratory-Grade Compounds
Evaluating a research peptide supplier comes down to four documents and one question each. HPLC purity tells you what proportion of the material is the target peptide by area under the curve — it does not tell you what the remainder is. LC-MS/MS tells you the molecular identity, which is the only reliable way to know that the powder in the vial is the molecule on the label. LAL endotoxin testing measures bacterial endotoxin load, not sterility. And a batch-specific Certificate of Analysis ties all three to the lot number printed on the vial, which is what makes a result reproducible. Most compounds sold on this market are not FDA-approved for human use, several are WADA-prohibited, and research-market material is not manufactured under pharmaceutical GMP.
All Articles
MOTS-c FDA Compounding 2026: Mitochondrial Peptide Research Guide
MOTS-c FDA compounding 2026 status affects research access to this 16-amino-acid mitochondrial peptide. Learn what the bulk list means for labs.
Thymosin Alpha-1 Research 2026: Immunity Peptide Study Guide
Thymosin Alpha-1 research covers a 28-amino acid immunomodulatory peptide with documented T-cell activation properties. This guide reviews mechanisms, FDA compounding context, and study parameters for 2026.
FDA Peptide Compounding Vote 2026: 7 Peptides Added to Bulk List
FDA peptide compounding vote 2026 result: PCAC recommends 7 peptides for the 503B bulk substances list. Full breakdown of compounds and regulatory implications.
GLP-3 Peptide Research: Mechanisms, Studies & Applications
GLP-3 peptide research reveals a proglucagon-derived incretin with distinct gut and metabolic signaling properties. Explore mechanisms, study data, and sourcing for research use.
SS-31: MITOCHONDRIA-TARGETING PEPTIDE SCIENCE, MECHANISMS, AND LABORATORY PROTOCOLS
SS31 (Elamipretide) is a synthetic, mitochondria-targeted tetrapeptide (D-Arg-2′6′-Dmt-Lys-Phe-NH₂) engineered to penetrate the inner mitochondrial membrane.
GHK-Cu Research Peptide: Mechanisms & Lab Protocols
GHK-Cu peptide is a tripeptide-copper complex studied for modulating over 4,000 genes, tissue remodeling, wound healing, and anti-inflammatory research.
Semaglutide vs Tirzepatide Discontinuation Research: Comparative Rebound Data 2026
Semaglutide vs tirzepatide discontinuation research reveals distinct rebound patterns, persistence rates, and reinitiation behaviors. 2025-2026 studies compare weight regain, metabolic reversal, and implications for high-purity research peptide protocols.
Peptide Express Fast Shipping: Research Timelines Explained
Peptide Express fast shipping delivers research-grade peptides in 1-3 business days domestically. Learn how order processing, quality testing, and cold-chain logistics work.
CagriSema vs Retatrutide: ADA 2026 Clinical Comparison Research
CagriSema retatrutide comparison reveals two distinct dual-agonist mechanisms targeting obesity. This guide covers receptor profiles, trial data, and research applications for 2026.
Injectable Peptide Regulation Gap 2026: JAMA Research Analysis
Injectable peptide regulation gaps identified in 2026 JAMA research reveal systemic oversight failures affecting lab-grade compound quality, purity verification, and research integrity.
Epitalon & Semax: Preclinical Neuroprotective Peptide Studies
Epitalon and Semax neuroprotective peptides show distinct bioregulatory mechanisms in preclinical models. This guide reviews published research on telomerase activation, BDNF upregulation, and receptor binding kinetics.
Retatrutide Phase 3 Trials 2026: What Researchers Need to Know
Retatrutide phase 3 trials in 2026 advance a triple incretin agonist through late-stage evaluation. This guide covers trial design, mechanisms, and research compound sourcing.
Melanotan-II Peptide Research: Abnormal Mole Development Studies
Melanotan-II peptide research reveals associations between MC1R activation and nevus development. Explore key studies, mechanisms, and safety data for researchers.
GLP-1 Cancer Research 2026: Breast & Prostate Tumor Slowdown Studies
GLP-1 cancer research in 2026 reveals that receptor agonists may slow tumor proliferation in breast and prostate models. This guide reviews the mechanisms, study data, and research implications.
MOTS-c Peptide Studies: 2026 Guide to Mitochondrial Metabolic Research
MOTS-c peptide studies reveal how this 16-amino-acid mitochondrial peptide activates AMPK, promotes mitochondrial biogenesis, and mimics exercise-induced metabolic effects in research models. Explore mechanisms, purity metrics, and procurement protocols.
Selank Research Peptide: Anxiolytic Mechanism & Lab Protocols 2026
Selank research peptide is a synthetic anxiolytic analog of Tuftsin that upregulates BDNF and modulates GABAergic transmission. This 2026 guide details molecular targets, intranasal dosing protocols, and lab-grade purity requirements for in-vitro and animal studies.
AI Peptide Antibiotic Optimization: 2026 Research Protocols & Data
AI peptide antibiotic optimization is reshaping 2026 antimicrobial research. Discover machine-learning peptide design, lab-validated assays, and sourcing standards for high-purity research peptides.
FDA Peptide Ban Reversal 2026: What Researchers Must Know Now
FDA peptide ban reversal could reopen 503B bulk list to cosmetic peptides by Q2 2026, restoring GHK-Cu, Argireline, and Matrixyl for dermatology research.
SS-31 Peptide Research Guide: Elamipretide & Mitochondrial Protection
SS-31 peptide research shows Elamipretide protects mitochondria by binding cardiolipin, reducing ROS 37%, and stabilizing cristae. This guide covers mechanism, purity metrics, and sourcing for labs.
Semaglutide Research Guide: Mechanisms, Dosing & Lab Protocols 2026
Semaglutide research guide covers GLP-1 receptor mechanisms, validated dosing protocols, purity standards, and lab study methods for 2026 peptide research.
Grey-Market Peptides Research: Mapping Public-Health Risk Vectors
Grey market peptides research exposes purity gaps, counterfeit rates near 37%, and endotoxin loads 18-fold above compendial limits. This data-driven risk analysis guides lab managers in sourcing third-party tested peptides.
Antimicrobial Peptides in Cancer Research 2026: Mechanisms & Trials
Antimicrobial peptides cancer research shows LL-37 and defensins trigger immunogenic cell death, inhibit angiogenesis, and enhance checkpoint blockade in 2026 pre-clinical models.
BPC-157 TB-500 Wolverine Kit: Research Mechanisms & Dosing Guide
BPC-157 TB-500 Wolverine Kit combines two research peptides studied for tissue repair. Learn mechanisms, dosing protocols, and sourcing standards for lab use.
Kisspeptin Research Guide: Mechanisms, Assays & Purity Standards 2026
Kisspeptin research guide covers receptor binding, GnRH release protocols, and high-purity peptide sourcing for reproductive neuroendocrine studies.
Epithalon Peptide Research Guide: Structure, Mechanism & Applications
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied for telomere biology, circadian gene regulation, and anti-aging markers in vitro. This research guide details its structure, mechanism, and lab applications.
FDA Approves Lilly's Foundayo: Research Implications
FDA approval of Lilly's Foundayo redefines GLP-1 research standards. This guide details molecular specs, receptor pharmacology, and procurement of research-grade analogs.
Amazon Bacteriostatic Water Ban: Peptide Reconstitution Alternatives
Amazon delisted all bacteriostatic water listings in Q2 2025, disrupting peptide reconstitution workflows for research labs. This guide reviews compliant sourcing, purity specifications, and sterile diluent alternatives validated for in-vitro peptide work.
FDA Peptide Restriction Lift: 2026
FDA peptide restriction lift expected in 2026 will reclassify several research peptides from Category II to Category I, expanding laboratory access to high-purity compounds for in-vitro and animal studies.
Novel Protein Reading Method in Bioengineering | Implications for Peptide Research
Discover the new protein reading method shaping peptide research. Learn its impact, applications, and how to source high-purity peptides for your studies.
BPC 157 Full Research Guide - Unlocking the Potential of Research Peptides
Discover the science behind BPC 157, its mechanisms, applications, and procurement as a high-purity research compound at Peptide.Express.
ENA101 Bispecific Peptide: DARKFOX-Targeting T Cell Engager Research
ENA101 bispecific peptide is a DARKFOX-targeting T cell engager designed for solid tumor immunotherapy research, bridging CD3-positive T cells to tumor antigens with high specificity.
MOTS-c Peptide Research: Mitochondrial Mechanisms & Metabolic Studies
MOTS-c peptide research explores a mitochondrial-derived peptide that regulates metabolic homeostasis. Learn its mechanisms, study parameters, and sourcing standards for research use.
PT-141 Bremelanotide Research Guide: Mechanisms, Studies & Applications
PT-141 bremelanotide is a synthetic melanocortin receptor agonist studied for its effects on central nervous system pathways. This guide covers mechanisms, pharmacokinetics, and research applications.
FDA Peptide Ban List 2025: What Research Labs Need to Know
FDA peptide ban list 2025 explained: which compounds are restricted, why compounding rules changed, and how research labs can maintain compliant procurement.
GHK-Cu Peptide Research: Anti-Aging, Skin & Tissue Repair Studies
GHK-Cu is a naturally occurring copper tripeptide studied for skin regeneration, wound healing, and anti-aging. A preclinical research guide for laboratory use.
BPC-157 TB-500 Blend Research: Synergistic Mechanisms Explained
BPC-157 TB-500 blend research explores two peptides with complementary tissue repair pathways. This guide covers mechanisms, data points, and sourcing for research use only.
Epithalon Peptide Research: Anti-Aging Mechanisms & Telomere Studies
Epithalon peptide research reveals telomere elongation and anti-aging pathways. This guide covers study findings, molecular data, and sourcing standards.
Anti-Aging Peptide Research: Compounds Behind the Trend
Anti-aging peptide research examines bioactive sequences that modulate collagen synthesis, cellular senescence, and longevity pathways. Discover the mechanisms driving this field in 2026.
Novo Nordisk Triple Agonist Obesity Peptide: GGG Tri-Agonist
Triple agonist obesity peptide research targets GIP, GLP-1, and glucagon receptors simultaneously. This guide covers mechanisms, study data, and sourcing standards for researchers.
Retatrutide vs Tirzepatide vs Semaglutide: Research Comparison Guide
Retatrutide vs tirzepatide vs semaglutide compared: receptor targets, pharmacokinetics, and preclinical findings for research use only. Full data breakdown inside.
CJC+Ipamorelin vs Tesamorelin: Which Research Peptide Is Better?
CJC+Ipamorelin vs Tesamorelin comparison explained: key differences in mechanism, half-life, selectivity, and research applications for growth hormone studies.
What Is BPC-157? Research Applications and Studies Guide
Discover what BPC-157 is, its research applications, and key studies. A comprehensive guide for researchers sourcing quality peptides for scientific study.
A Comprehensive Research Guide: Getting Started with Peptides
Discover the essentials of peptide research, including types, applications, quality assurance, and purity testing methods for reliable and reproducible results.